CERUS CORP

CERS ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $233.8M $201.3M $186.8M $188.3M $159.5M $114.2M $93.8M
Cost of Revenue $41.2M $33.4M
Gross Profit $73.1M $60.4M
Gross Margin 64.0% 64.4%
Operating Expenses
Research & Development
SG&A Expense $80.9M $75.9M $75.5M $83.3M $81.3M $67.0M $66.2M
Operating Income $-8.7M $-14.2M $-30.1M $-34.1M $-48.9M $-58.3M $-66.2M
Operating Margin -3.7% -7.1% -16.1% -18.1% -30.7% -51.1% -70.6%
Interest Expense $8.4M $5.8M $4.9M $3.7M $6.1M
Pretax Income $-15.3M $-20.8M $-37.3M $-42.3M $-54.1M $-59.6M $-71.0M
Income Tax Expense $354.0K $205.0K $325.0K $488.0K $319.0K $284.0K $263.0K
Net Income $-15.6M $-20.9M $-37.5M $-42.8M $-54.4M $-59.9M $-71.2M
Net Margin -6.7% -10.4% -20.1% -22.7% -34.1% -52.4% -76.0%
EPS (Basic) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51
EPS (Diluted) $-0.08 $-0.11 $-0.21 $-0.24 $-0.32 $-0.37 $-0.51
Shares Outstanding (Basic) 192.2M 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M
Shares Outstanding (Diluted) 192.2M 190.6M 184.6M 180.3M 176.5M 171.3M 163.9M 139.8M
Dividends Per Share
← Newer Page 1 of 3 Older →